- call +1-201-465-4211
- email sales@mrinsights.biz
Scope of the Report:
This report focuses on the Antihypertensive in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Increase in blood pressure is measured in terms of systolic and diastolic blood pressure exerted by blood on the wall of artery and hence it is also termed as arterial hypertension. Reduction in blood pressure minimizes the risk of heart failure, ischaemic heart diseases, dementia and mortality due to hypertension.
Antihypertensives are the drugs that are used to treat high blood pressure. This type of drug alleviate the complications of stroke and myocardial infarction.
The worldwide market for Antihypertensive is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Pfizer
Novartis
Sanofi
Merck
Boehringer Ingelheim
Lupin
Johnson & Johnson
Astra Zeneca
Daiichi Sankyo
Ranbaxy
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Diuretics
Angiotensin receptor blockers (ARBs)
Angiotensin converting enzyme (ACE) inhibitors
Beta blockers
Alpha blockers
Calcium channel blockers
Renin inhibitors
Vasodilators
Market Segment by Applications, can be divided into
Hosptial
Clinic
Home
There are 15 Chapters to deeply display the global Antihypertensive market.
Chapter 1, to describe Antihypertensive Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Antihypertensive, with sales, revenue, and price of Antihypertensive, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Antihypertensive, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Antihypertensive market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Antihypertensive sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Antihypertensive Introduction
1.2 Market Analysis by Type
1.2.1 Diuretics
1.2.2 Angiotensin receptor blockers (ARBs)
1.2.3 Angiotensin converting enzyme (ACE) inhibitors
1.2.4 Beta blockers
1.2.5 Alpha blockers
1.2.6 Calcium channel blockers
1.2.7 Renin inhibitors
1.2.8 Vasodilators
1.3 Market Analysis by Applications
1.3.1 Hosptial
1.3.2 Clinic
1.3.3 Home
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Antihypertensive Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Antihypertensive Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sanofi
2.3.1 Business Overview
2.3.2 Antihypertensive Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Antihypertensive Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Antihypertensive Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Lupin
2.6.1 Business Overview
2.6.2 Antihypertensive Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lupin Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Johnson & Johnson
2.7.1 Business Overview
2.7.2 Antihypertensive Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson & Johnson Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Astra Zeneca
2.8.1 Business Overview
2.8.2 Antihypertensive Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Astra Zeneca Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Daiichi Sankyo
2.9.1 Business Overview
2.9.2 Antihypertensive Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Daiichi Sankyo Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ranbaxy
2.10.1 Business Overview
2.10.2 Antihypertensive Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Ranbaxy Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Antihypertensive Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Antihypertensive Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antihypertensive Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Antihypertensive Manufacturer Market Share in 2017
3.3.2 Top 6 Antihypertensive Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Antihypertensive Market Analysis by Regions
4.1 Global Antihypertensive Sales, Revenue and Market Share by Regions
4.1.1 Global Antihypertensive Sales and Market Share by Regions (2013-2018)
4.1.2 Global Antihypertensive Revenue and Market Share by Regions (2013-2018)
4.2 North America Antihypertensive Sales and Growth Rate (2013-2018)
4.3 Europe Antihypertensive Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Antihypertensive Sales and Growth Rate (2013-2018)
4.5 South America Antihypertensive Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Antihypertensive Sales and Growth Rate (2013-2018)
5 North America Antihypertensive by Countries
5.1 North America Antihypertensive Sales, Revenue and Market Share by Countries
5.1.1 North America Antihypertensive Sales and Market Share by Countries (2013-2018)
5.1.2 North America Antihypertensive Revenue and Market Share by Countries (2013-2018)
5.2 United States Antihypertensive Sales and Growth Rate (2013-2018)
5.3 Canada Antihypertensive Sales and Growth Rate (2013-2018)
5.4 Mexico Antihypertensive Sales and Growth Rate (2013-2018)
6 Europe Antihypertensive by Countries
6.1 Europe Antihypertensive Sales, Revenue and Market Share by Countries
6.1.1 Europe Antihypertensive Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Antihypertensive Revenue and Market Share by Countries (2013-2018)
6.2 Germany Antihypertensive Sales and Growth Rate (2013-2018)
6.3 UK Antihypertensive Sales and Growth Rate (2013-2018)
6.4 France Antihypertensive Sales and Growth Rate (2013-2018)
6.5 Russia Antihypertensive Sales and Growth Rate (2013-2018)
6.6 Italy Antihypertensive Sales and Growth Rate (2013-2018)
7 Asia-Pacific Antihypertensive by Countries
7.1 Asia-Pacific Antihypertensive Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Antihypertensive Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Antihypertensive Revenue and Market Share by Countries (2013-2018)
7.2 China Antihypertensive Sales and Growth Rate (2013-2018)
7.3 Japan Antihypertensive Sales and Growth Rate (2013-2018)
7.4 Korea Antihypertensive Sales and Growth Rate (2013-2018)
7.5 India Antihypertensive Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Antihypertensive Sales and Growth Rate (2013-2018)
8 South America Antihypertensive by Countries
8.1 South America Antihypertensive Sales, Revenue and Market Share by Countries
8.1.1 South America Antihypertensive Sales and Market Share by Countries (2013-2018)
8.1.2 South America Antihypertensive Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Antihypertensive Sales and Growth Rate (2013-2018)
8.3 Argentina Antihypertensive Sales and Growth Rate (2013-2018)
8.4 Colombia Antihypertensive Sales and Growth Rate (2013-2018)
9 Middle East and Africa Antihypertensive by Countries
9.1 Middle East and Africa Antihypertensive Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Antihypertensive Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Antihypertensive Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Antihypertensive Sales and Growth Rate (2013-2018)
9.3 UAE Antihypertensive Sales and Growth Rate (2013-2018)
9.4 Egypt Antihypertensive Sales and Growth Rate (2013-2018)
9.5 Nigeria Antihypertensive Sales and Growth Rate (2013-2018)
9.6 South Africa Antihypertensive Sales and Growth Rate (2013-2018)
10 Global Antihypertensive Market Segment by Type
10.1 Global Antihypertensive Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Antihypertensive Sales and Market Share by Type (2013-2018)
10.1.2 Global Antihypertensive Revenue and Market Share by Type (2013-2018)
10.2 Diuretics Sales Growth and Price
10.2.1 Global Diuretics Sales Growth (2013-2018)
10.2.2 Global Diuretics Price (2013-2018)
10.3 Angiotensin receptor blockers (ARBs) Sales Growth and Price
10.3.1 Global Angiotensin receptor blockers (ARBs) Sales Growth (2013-2018)
10.3.2 Global Angiotensin receptor blockers (ARBs) Price (2013-2018)
10.4 Angiotensin converting enzyme (ACE) inhibitors Sales Growth and Price
10.4.1 Global Angiotensin converting enzyme (ACE) inhibitors Sales Growth (2013-2018)
10.4.2 Global Angiotensin converting enzyme (ACE) inhibitors Price (2013-2018)
10.5 Beta blockers Sales Growth and Price
10.5.1 Global Beta blockers Sales Growth (2013-2018)
10.5.2 Global Beta blockers Price (2013-2018)
10.6 Alpha blockers Sales Growth and Price
10.6.1 Global Alpha blockers Sales Growth (2013-2018)
10.6.2 Global Alpha blockers Price (2013-2018)
10.7 Calcium channel blockers Sales Growth and Price
10.7.1 Global Calcium channel blockers Sales Growth (2013-2018)
10.7.2 Global Calcium channel blockers Price (2013-2018)
10.8 Renin inhibitors Sales Growth and Price
10.8.1 Global Renin inhibitors Sales Growth (2013-2018)
10.8.2 Global Renin inhibitors Price (2013-2018)
10.9 Vasodilators Sales Growth and Price
10.9.1 Global Vasodilators Sales Growth (2013-2018)
10.9.2 Global Vasodilators Price (2013-2018)
11 Global Antihypertensive Market Segment by Application
11.1 Global Antihypertensive Sales Market Share by Application (2013-2018)
11.2 Hosptial Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
11.4 Home Sales Growth (2013-2018)
12 Antihypertensive Market Forecast (2018-2023)
12.1 Global Antihypertensive Sales, Revenue and Growth Rate (2018-2023)
12.2 Antihypertensive Market Forecast by Regions (2018-2023)
12.2.1 North America Antihypertensive Market Forecast (2018-2023)
12.2.2 Europe Antihypertensive Market Forecast (2018-2023)
12.2.3 Asia-Pacific Antihypertensive Market Forecast (2018-2023)
12.2.4 South America Antihypertensive Market Forecast (2018-2023)
12.2.5 Middle East and Africa Antihypertensive Market Forecast (2018-2023)
12.3 Antihypertensive Market Forecast by Type (2018-2023)
12.3.1 Global Antihypertensive Sales Forecast by Type (2018-2023)
12.3.2 Global Antihypertensive Market Share Forecast by Type (2018-2023)
12.4 Antihypertensive Market Forecast by Application (2018-2023)
12.4.1 Global Antihypertensive Sales Forecast by Application (2018-2023)
12.4.2 Global Antihypertensive Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Antihypertensive Picture
Table Product Specifications of Antihypertensive
Figure Global Sales Market Share of Antihypertensive by Types in 2017
Table An
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
